Skip to main content
Log in

Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The in vitro activity of S-25930 and S-25932, two new quinolone antimicrobial agents, against 306 gram-positive organisms representing 12 bacterial species, was evaluated and compared with the activity of ciprofloxacin, difloxacin, enoxacin, amifloxacin and A-56620. Both agents were active against staphylococcal species (including methicillin-resistant and coagulase-negative isolates),Bacillus spp. and group JK diphtheroids. They were less active against streptococcal species andListeria monocytogenes. Their activity against most isolates was superior to that of amifloxacin, enoxacin and difloxacin and similar to that of ciprofloxacin and A-56620.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rolston, K. V. I., Ho, D. H., LeBlanc, B., Bodey, G. P. In vitro evaluation of S-25930 and S-25932, two new quinolones against aerobic gram-negative isolates from cancer patients. Antimicrobial Agents and Chemotherapy 1987, 31: 102–103.

    PubMed  Google Scholar 

  2. Fass, R.J. The quinolones. Annals of Internal Medicine 1985, 102: 400–402.

    PubMed  Google Scholar 

  3. Rolston, K. V. I., LeBlanc, B., Ho, D. H., Bodey, G. P. In vitro activity of paldimycin (V-70138F) against gram-positive bacteria isolated from patients with cancer. Antimicrobial Agents and Chemotherapy 1987, 31: 650–652.

    PubMed  Google Scholar 

  4. Kloos, W. E., Schleifer, K. M. Simplified scheme for routine identification of humanStaphylococcus species. Journal of Clinical Microbiology 1975, 1: 82–88.

    Google Scholar 

  5. Kloos, W. E., Wolfschool, J. F. Identification ofStaphylococcus species with the API Staph-Ident system. Journal of Clinical Microbiology 1982, 16: 509–516.

    PubMed  Google Scholar 

  6. Jones, P. G., Rolston, K. V. I., Fainstein, V., Elting, L., Walters, R. S., Bodey, G. P. Aztreonam therapy in neutropenic patients with cancer. American Journal of Medicine 1986, 81: 243–248.

    PubMed  Google Scholar 

  7. Facklam, R. R., Carey, R. B. Streptococci and aerococci. In: Lennette, E. M., Balows, A., Hausler, W. J., Shadomy, H. J. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985, p. 154–175.

    Google Scholar 

  8. Neu, H. C., Chin, N. In vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents. Journal of Antimicrobial Chemotherapy 1987, 19: 175–185.

    PubMed  Google Scholar 

  9. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A. Villanova, PA, 1985.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rolston, K.V.I., Ho, D.H., LeBlanc, B. et al. Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients. Eur. J. Clin. Microbiol. Infect. Dis. 7, 681–683 (1988). https://doi.org/10.1007/BF01964254

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964254

Keywords

Navigation